HtrA Serine Proteases as Potential Therapeutic Targets in Cancer
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
451-468
Author(s):
Jeremy Chien, Mara Campioni, Viji Shridhar and Alfonso Baldi
The Biological Functions of NF-κB1 (p ) and its Potential as an Anti-Cancer Target
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
566-571
Author(s):
Yonghui Yu, Yu Wan and Chuanshu Huang
Potential Uses of MicroRNA in Lung Cancer Diagnosis, Prognosis, and Therapy
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
572-594
Author(s):
Qi Zhao Wang, William Xu, Nagy Habib and Ruian Xu
The Role of Proteomics in Osteoarthritis Pathogenesis Research
Journal:
Current Drug Targets
Volume:
10
Page:
543-556
Author(s):
Cristina Ruiz-Romero and Francisco J. Blanco
STAT3 Regulation of Glioblastoma Pathogenesis
Journal:
Current Molecular Medicine
Volume:
9
Page:
580-590
Author(s):
Nuria de la Iglesia, Sidharth V. Puram and Azad Bonni
STAT3 as a Central Regulator of Tumor Metastases
Journal:
Current Molecular Medicine
Volume:
9
Page:
626-633
Author(s):
Eswaran Devarajan and Suyun Huang
In Search of the Most Suitable Lentiviral shRNA System
Journal:
Current Gene Therapy
Volume:
9
Page:
192-211
Author(s):
Tomas Jan Bos, Elke De Bruyne, Carlo Heirman and Karin Vanderkerken
Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
Journal:
Current Drug Metabolism
Volume:
10
Page:
470-481
Author(s):
Jorg Thomas Hartmann, Michael Haap, Hans-Georg Kopp and Hans-Peter Lipp
Vitamin D and the Adaptive Immune System with Special Emphasis to Allergic Reactions and Allograft Rejection
Journal:
Inflammation & Allergy - Drug Targets (Discontinued)
Volume:
8
Page:
161-168
Author(s):
Armin Zittermann, Gero Tenderich and Reiner Koerfer
Targeting Indoleamine 2,3-dioxygenase (IDO) to Counteract Tumour- Induced ImmuneDysfunction: From Biochemistry to Clinical Development
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
9
Page:
151-177
Author(s):
S. Rutella, G. Bonanno and R. De Cristofaro